Medical News / Low-Molecular-Weight Heparin Non-Superior to Standard Therapy in Reducing Miscarriages

Low-molecular-weight heparin (LMWH) did not increase the live-birth rate in comparison to standard therapy for pregnant women. A team, led by Siobhan Quenby, MD, PhD, Biomedical Research Unit in Reproductive Health, University of Warwick, compared the 2 treatments in a cohort of pregnant women in several countries. The data was presented during the American Society of Hematology (ASH) Annual Meeting and Exposition. Source: MDMag To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

MORE MEDICAL NEWS
Reporting from AAD 2023 - Henry Lim, MD: Discussing Photoprotection Needs for Skin of Color
Henry Lim, MD, spoke with HCPLive about major takeaways from his presentation at the American Academy ... read more
Directly from AAD 2023: Oral TYK2 Inhibitor Led to Significant Skin Clearance Improvement in Psoriasis
An oral tyrosine kinase 2 (TYK2) inhibitor, called NDI-034858, led to substantial skin clearance improvement for ... read more
Reporting from AAD 2023 - Ester Del Duca, MD: Molecular Phenotype Differences in African Eczema Patients
New late-breaking data presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting in New ... read more
From AAD 2023: Promising Phase 2 Data on Septa-Specific Monoclonal Antibody for Hidradenitis Suppurativa
Late-breaking data presented at the the American Academy of Dermatology (AAD) 2023 Annual Meeting in New ... read more